Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001079973-25-000339·28 Consultants Ltd
Schedule 13G ownership disclosure
CYTOMED THERAPEUTICS LIMITED
Ordinary Shares, no par value · CUSIP: Y1R80M106
Event date: 2025-02-17
- Filing-level shares
- 880,313.00
- Percent of class
- 7.62%
- 28 Consultants Ltd
Shares: 880,313.00 · Class: 7.62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000339
- Form type
- SCHEDULE 13G
- Filer
- 28 Consultants Ltd
- CIK
- CIK 2058868
- Filed
- Mar 04, 2025
- Reporting period
- Feb 17, 2025
- Description
- Schedule 13G beneficial ownership